Literature DB >> 30880473

What is the best method to determine excessive arm volume in patients with breast cancer-related lymphoedema in clinical practice? Reliability, time efficiency and clinical feasibility of five different methods.

Tessa De Vrieze1,2, Nick Gebruers2,3, Wiebren Aa Tjalma3,4,5, Ines Nevelsteen6, Sarah Thomis7, An De Groef1, Lore Dams1,2, Elien Van der Gucht1,2, Jean-Paul Belgrado8, Liesbeth Vandermeeren8, Nele Devoogdt1,7.   

Abstract

OBJECTIVE: To investigate the reliability, time efficiency and clinical feasibility of five commonly used methods for assessing excessive arm volume in patients with breast cancer-related lymphoedema (BCRL).
DESIGN: Cross-sectional study.
SETTING: University Hospitals Leuven, Belgium.
SUBJECTS: 30 participants with unilateral BCRL.
METHODS: Excessive arm volume was determined by five different methods: traditional volumetry with overflow, volumetry without overflow, inverse volumetry, optoelectronic volumetry and calculated volume based on circumference measurements. To investigate intra- and inter-rater reliability, measurements were performed twice by the same assessor and once by a different assessor. Intraclass correlation coefficients (ICCs), standard errors of the measurement (SEMs) and systematic changes between the means were calculated. To determine time efficiency, the mean setup time, execution time and total time were examined for each method. Furthermore, 12 limitations regarding clinical feasibility were listed and scored for each method. Finally, an overall ranking score was determined between the methods.
RESULTS: Mean age was 65 (±8) years and mean body mass index was 28 (±4) kg/m2. Intra- and inter-rater reliability ranged between strong and very strong. Calculated arm volume based on circumferences (mean excessive arm volume: assessor A: 477 (±367) mL; assessor B: 470 (±367) mL; assessor A (second time): 493 (±362) mL) showed the highest intra- and inter-rater ICCs of .987 and .984, respectively. Optoelectronic volumetry was the fastest method, representing a mean total time of 1 minute and 43 (±26) seconds for performing a bilateral measurement. The least limitations were reported on the calculated volume based on the circumference method (3 out of 12 limitations).
CONCLUSION: Calculated volume based on arm circumferences is the best measurement method for evaluating excessive arm volume over time in terms of reliability, low error rate, low cost, few limitations and the time spent.

Entities:  

Keywords:  Breast neoplasms; assessment; feasibility; lymphoedema; reliability; time efficiency

Mesh:

Year:  2019        PMID: 30880473     DOI: 10.1177/0269215519835907

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  4 in total

1.  The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements.

Authors:  Pınar Borman; Ayşegül Yaman; Lütfi Doğan; Ayşe Arıkan Dönmez; Esra Gizem Koyuncu; Ayşegül Balcan; Sercan Aksoy; Cihangir Özaslan; Rabiye Akın; Kaniye Üneş
Journal:  Eur J Breast Health       Date:  2022-04-01

2.  Response to Letter to the Editor: The importance of discussing physical exercise in women with breast cancer-related lymphedema.

Authors:  Vesile Yildiz Kabak; Ceren Gursen; Ayca Aytar; Turkan Akbayrak; Tulin Duger
Journal:  Support Care Cancer       Date:  2022-09-24       Impact factor: 3.359

3.  Self-administration of complex decongestive therapy facilitated by the mobile application WeChat improves lymphedema and quality of life in breast cancer survivors: an observational study.

Authors:  Xu Liang; Miaoning You; Cuiju Wen; Fengzhen Hou; Jingjing Kang; Zhihua Lv; Jun Tian
Journal:  Ann Transl Med       Date:  2022-02

4.  Clinical application of low-level laser therapy (Photo-biomodulation therapy) in the management of breast cancer-related lymphedema: a systematic review.

Authors:  Dania Mahmood; Ashfaq Ahmad; Faiza Sharif; Syed Asadullah Arslan
Journal:  BMC Cancer       Date:  2022-08-30       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.